Parameters | Mild | Severe |
---|---|---|
Subjects enrolled | n = 30 | n = 15 |
Median age (range) | 39 (18–81) | 48 (22–70) |
Gender (M/F) | 14/16 | 12/3 |
Fever, no. (%) | 17 (57) | 13 (87) |
Chills, no. (%) | 4 (13) | 6 (40) |
Cough, no. (%) | 15 (50) | 7 (47) |
Sore throat, no. (%) | 16 (53) | 5 (33) |
Runny nose, no. (%) | 5 (17) | 2 (13) |
Taste loss, no. (%) | 21 (70) | 5 (33) |
Smell loss, no. (%) | 17 (57) | 6 (40) |
Muscle aches, no. (%) | 24 (80) | 9 (60) |
Joint pain, no. (%) | 18 (60) | 5 (33) |
Abdominal pain, no. (%) | 2 (7) | 1 (7) |
Vomit, no. (%) | 2 (7) | 1 (7) |
Diarrhea, no. (%) | 4 (13) | 6 (40) |
Seizures, no. (%) | NIL | NIL |
Hypertension, no. (%) | 7 (23) | 5 (33) |
Diabetes, no. (%) | 4 (13) | 4 (27) |
Asthma, no. (%) | 1 (3) | 1 (7) |
Chronic kidney disease, no. (%) | NIL | NIL |
Neuro, no. (%) | NIL | NIL |
Heart, no. (%) | NIL | 1 (7) |
Rheumatic fever, no. (%) | NIL | NIL |
Corticosteroids, no. (%) | NIL | 3 (20) |
Antiviral drug, no. (%) | NIL | 4 (27) |
Required hospitalization no. (%) | NIL | 6 (40) |
Required mechanical oxygen support no. (%) | NIL | NIL |